informed consent procedure with electronic signature. Participants then completed questions related to standard inclusion and exclusion criteria such as age (18–70 years), agreement to participate, and exclusion based on a history of bleeding disorders, current use of anti- coagulant medications, immune disorders, diabetes, planned surgery, or pregnancy, among other criteria. The subjects agreed to not change their current diet or exercise program and to stop using all other dietary supplements, including their present omega 3 fish oil supplement, for a two-week wash-out period before onset of the study and for the duration of the interven- tion. Subjects were then scheduled to undergo a phone screen with a trained clinical staff member. This phone screening also ensured the subjects understood their rights and responsibilities related to the study prior to their participation.